Subscribe To

Price Alert Latest News Economic Calendar News

LABD / The Sell Rating Of LABD Is Reaffirmed

Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology sector has done relatively well during the last four months; it is expected to continue trading sideways. Read More

Demo Live Account See Partner Details

Content Topics

Sell

Rating

LABD

Reaffirmed

Stock

Posted: Nov 3 2022, 03:36

Author Name: Seeking Alpha

LABD News

By Seeking Alpha
September 29, 2023

LABU And LABD: Another Attractive Double-Short Pairs Trade

Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both asse

By Seeking Alpha
July 21, 2023

LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided

Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don't foresee this fund genera

By Zacks Investment Research
March 27, 2023

5 Best Leveraged ETFs of Last Week

Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street.

By Seeking Alpha
November 3, 2022

The Sell Rating Of LABD Is Reaffirmed

Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology se

By Seeking Alpha
March 18, 2022

LABD: 3X Leveraged Investments Not Suitable For Long Term

3X inverse derivative investments are extremely volatile and risky.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.